FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017173899> ?p ?o ?g. }

• W2017173899 endingPage "737" @default.
• W2017173899 startingPage "736" @default.
• W2017173899 abstract "Sir, Ketolides are a new class of semisynthetic macrolide derivatives that show excellent activity against Streptococcus pneumoniae, even against erythromycin-resistant isolates. Previous investigators have not found any telithromycin-resistant isolates among S. pneumoniae with the constitutive macrolide–lincosamide–streptogramin B (cMLSB) phenotype, even though staphylococci or Streptococcus pyogenes with the cMLSB phenotype can develop resistance to this drug.1–3 The lack of induction of methylase production by this drug is one reason for such a difference.4 Recently, Hamilton-Miller & Shah5 reported that resistance to the ketolide cethromycin (formerly ABT-773) could be induced in S. pneumoniae with the cMLSB phenotype by erythromycin or other related antibiotics. In this study, we examined whether 55 isolates of erythromycin-resistant S. pneumoniae (MIC ≥ 1 mg/L) carrying the mef(A) and/or erm(B) genes could develop resistance to telithromycin, a ketolide with different substitutions from cethromycin (ABT-773), when exposed to erythromycin. Fifty-five clinical isolates of erythromycin-resistant S. pneumoniae (obtained from the sputum of patients with lower respiratory tract infections between 1998 and 2000) were used. These isolates were identified by their sensitivity to optochin and the bile solubility test, and by PCR amplification of the lytA gene. S. pneumoniae ATCC 6305 was used as the quality control strain. Reference samples of the following antimicrobial agents of known potency were kindly supplied in powder form by the indicated manufacturers: erythromycin (Shionogi Pharmaceutical Co., Osaka, Japan), clarithromycin (Taisho Pharmaceutical Co., Tokyo, Japan), azithromycin (Pfizer Laboratories, Groton, CT, USA), rokitamycin (Asahi Kasei, Tokyo, Japan), telithromycin (Nippon HoechstMarion-Roussel, Tokyo, Japan) and clindamycin (Upjohn, Tokyo, Japan). All isolates were tested for susceptibility to the six antibiotics listed above at concentrations between 0.015 and 128 mg/L. MICs were determined by the two-fold agar dilution method using susceptibility test agar (Mueller–Hinton agar medium; Eiken Chemicals, Tokyo, Japan) with 8% Strepto Haemo supplement (SHS; Eiken Chemicals). DNA was obtained as previously reported, and the presence of macrolide resistance genes was investigated by PCR using primers and amplification conditions that have been described previously.6 Induction of telithromycin resistance was examined by the following two methods. (i) Agar dilution method: induction of telithromycin resistance was evaluated by comparing the MICs for telithromycin in the presence and absence of a subinhibitory concentration of erythromycin (0.1 mg/L). Two susceptibility agar plates were prepared for each isolate: one contained only telithromycin and the other contained telithromycin plus erythromycin. The MIC was determined in accordance with the susceptibility test. (ii) Disc diffusion method: A bacterial suspension (2 mL of ∼108 cfu/mL) was inoculated onto 10 mL of susceptibility test agar containing 8% SHS and spread over the surface. After excess suspension was removed, paper discs (8 mm diameter high discs; Tokyo Roshi Kaisha, Tokyo, Japan) containing erythromycin or rokitamycin at 20 μg/disc or telithromycin at 5 μg/disc were placed on the surface of the agar plate. Then the plates were incubated overnight at 35°C and induction of telithromycin resistance was assessed from the shape of the zone of inhibition around the telithromycin disc nearest either the erythromycin or the rokitamycin disc. Fifteen isolates carrying only the mef(A) gene had the M phenotype. Among the other 40 isolates, 25 carried the erm(B) gene, and 15 had both the mef(A) and erm(B) genes. All 40 isolates showed a high" @default.
• W2017173899 created "2016-06-24" @default.
• W2017173899 creator A5004740539 @default.
• W2017173899 creator A5004864001 @default.
• W2017173899 creator A5009953586 @default.
• W2017173899 creator A5026956856 @default.
• W2017173899 creator A5038071866 @default.
• W2017173899 creator A5044093901 @default.
• W2017173899 creator A5059333576 @default.
• W2017173899 creator A5072090509 @default.
• W2017173899 date "2003-09-01" @default.
• W2017173899 modified "2023-09-27" @default.
• W2017173899 title "Induction of telithromycin resistance in Streptococcus pneumoniae" @default.
• W2017173899 cites W1967408737 @default.
• W2017173899 cites W2018011211 @default.
• W2017173899 cites W2030034943 @default.
• W2017173899 cites W2039566390 @default.
• W2017173899 cites W2099788322 @default.
• W2017173899 cites W2120736676 @default.
• W2017173899 cites W2129600266 @default.
• W2017173899 cites W2132344375 @default.
• W2017173899 cites W2134527953 @default.
• W2017173899 cites W2139666805 @default.
• W2017173899 cites W2985729189 @default.
• W2017173899 doi "https://doi.org/10.1093/jac/dkg411" @default.
• W2017173899 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12951334" @default.
• W2017173899 hasPublicationYear "2003" @default.
• W2017173899 type Work @default.
• W2017173899 sameAs 2017173899 @default.
• W2017173899 citedByCount "6" @default.
• W2017173899 countsByYear W20171738992016 @default.
• W2017173899 crossrefType "journal-article" @default.
• W2017173899 hasAuthorship W2017173899A5004740539 @default.
• W2017173899 hasAuthorship W2017173899A5004864001 @default.
• W2017173899 hasAuthorship W2017173899A5009953586 @default.
• W2017173899 hasAuthorship W2017173899A5026956856 @default.
• W2017173899 hasAuthorship W2017173899A5038071866 @default.
• W2017173899 hasAuthorship W2017173899A5044093901 @default.
• W2017173899 hasAuthorship W2017173899A5059333576 @default.
• W2017173899 hasAuthorship W2017173899A5072090509 @default.
• W2017173899 hasBestOaLocation W20171738991 @default.
• W2017173899 hasConcept C2778663903 @default.
• W2017173899 hasConcept C2780810561 @default.
• W2017173899 hasConcept C2780894585 @default.
• W2017173899 hasConcept C2781253189 @default.
• W2017173899 hasConcept C501593827 @default.
• W2017173899 hasConcept C71924100 @default.
• W2017173899 hasConcept C86803240 @default.
• W2017173899 hasConcept C89423630 @default.
• W2017173899 hasConceptScore W2017173899C2778663903 @default.
• W2017173899 hasConceptScore W2017173899C2780810561 @default.
• W2017173899 hasConceptScore W2017173899C2780894585 @default.
• W2017173899 hasConceptScore W2017173899C2781253189 @default.
• W2017173899 hasConceptScore W2017173899C501593827 @default.
• W2017173899 hasConceptScore W2017173899C71924100 @default.
• W2017173899 hasConceptScore W2017173899C86803240 @default.
• W2017173899 hasConceptScore W2017173899C89423630 @default.
• W2017173899 hasIssue "4" @default.
• W2017173899 hasLocation W20171738991 @default.
• W2017173899 hasLocation W20171738992 @default.
• W2017173899 hasOpenAccess W2017173899 @default.
• W2017173899 hasPrimaryLocation W20171738991 @default.
• W2017173899 hasRelatedWork W1574139222 @default.
• W2017173899 hasRelatedWork W1972321258 @default.
• W2017173899 hasRelatedWork W1979157949 @default.
• W2017173899 hasRelatedWork W2012839636 @default.
• W2017173899 hasRelatedWork W2030034943 @default.
• W2017173899 hasRelatedWork W2055498541 @default.
• W2017173899 hasRelatedWork W2127635184 @default.
• W2017173899 hasRelatedWork W2157724669 @default.
• W2017173899 hasRelatedWork W2161157728 @default.
• W2017173899 hasRelatedWork W2168122682 @default.
• W2017173899 hasVolume "52" @default.
• W2017173899 isParatext "false" @default.
• W2017173899 isRetracted "false" @default.
• W2017173899 magId "2017173899" @default.
• W2017173899 workType "article" @default.